Drug Shortage Report for VFEND FOR INJECTION

Last updated on 2017-08-19 History
Report ID 10074
Drug Identification Number 02256487
Brand name VFEND FOR INJECTION
Common or Proper name VFEND
Company Name PFIZER CANADA ULC
Active Ingredient(s) VORICONAZOLE
Strength(s) 200MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size each
ATC code J02AC
ATC description ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-05-31
Actual start date
Estimated end date 2017-08-18
Actual end date 2017-08-18
Shortage status Resolved
Updated date 2017-08-19
Company comments Released August 18, 2017. Inventory is currently available through the CPDN network and projected to cover demand to early June.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2017-08-19 English Compare
v18 2017-08-18 French Compare
v17 2017-08-18 English Compare
v16 2017-08-16 French Compare
v15 2017-08-16 English Compare
v14 2017-08-08 French Compare
v13 2017-08-08 English Compare
v12 2017-08-07 French Compare
v11 2017-08-07 English Compare
v10 2017-07-24 French Compare
v9 2017-07-24 French Compare
v8 2017-07-24 English Compare
v7 2017-07-18 French Compare
v6 2017-07-18 English Compare
v5 2017-07-11 French Compare
v4 2017-07-11 English Compare
v3 2017-06-01 English Compare
v2 2017-05-11 French Compare
v1 2017-05-11 English Compare